| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.3 | 0.0002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |